Study of MultI-eLectrode EndovaScular denervaTiOn in patieNts with type 2 diabetes mEllitus (MILESTONE): 6-month analysis from the first-in-human proof-of-concept study

被引：0
|
作者：
Pan, T. [1 ]
Wang, Z. [1 ]
Teng, G. -J. [1 ]
机构：
[1] Southeast Univ, Nanjing, Peoples R China
来源：
DIABETOLOGIA | 2023年 / 66卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
102
引用
收藏
页码：S55 / S55
页数：1
相关论文
共 50 条
  • [21] ENDOSCOPIC DUODENAL SUBMUCOSAL LASER ABLATION FOR THE TREATMENT OF TYPE 2 DIABETES MELLITUS - RESULTS OF FIRST-IN-HUMAN PILOT STUDY
    Mraz, M.
    Levy, B.
    Lankova, I.
    Kratochvilova, H.
    Cinkajzlova, A.
    Benes, M.
    Korner, J.
    Vlasakova, Z.
    Spicak, J.
    Pelikanova, T.
    Haluzik, M.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2020, 22 : A206 - A206
  • [22] Effects of exenatide on measures of diabetic neuropathy in subjects with type 2 diabetes: results from an 18-month proof-of-concept open-label randomized study
    Jaiswal, Mamta
    Martin, Catherine L.
    Brown, Morton B.
    Callaghan, Brian
    Albers, James W.
    Feldman, Eva L.
    Pop-Busui, Rodica
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2015, 29 (08) : 1287 - 1294
  • [23] Factors Associated with First Injectable Glucose-Lowering Treatment in Patients with Type 2 Diabetes and 6-Month Treatment Outcomes: Data from the CHOICE Study in Germany
    Reaney, M.
    Matthaei, S.
    Kiljanski, J.
    Nicolay, C.
    DIABETOLOGIE UND STOFFWECHSEL, 2012, 7 (02) : 133 - 141
  • [24] Baseline and 6-month vascular risk profile in patients with type 2 diabetes Mellitus according to EDPG glucose and lipid assessment levels -: an observational study in Spain -: 6 month follow-up
    Rodríguez, A
    Zanoletty, A
    Cuesta, R
    Reviriego, J
    PROCEEDINGS OF THE 12TH INTERNATIONAL CONGRESS OF ENDOCRINOLOGY, 2004, : 633 - 639
  • [25] XC001 gene therapy for the treatment of refractory angina: 6-month efficacy and safety from the phase 1/2 first-in-human study (EXACT Trial)
    Stewart, D. J.
    Dittrich, H. C.
    Reinhardt, R. R.
    Rosengart, T. K.
    Crystal, R. G.
    Povsic, T. J.
    HUMAN GENE THERAPY, 2024, 35 (3-4) : A44 - A44
  • [26] THE REAL-WORLD OBSERVATIONAL PROSPECTIVE STUDY OF HEALTH OUTCOMES WITH DULAGLUTIDE & LIRAGLUTIDE IN TYPE 2 DIABETES PATIENTS (TROPHIES): 6-MONTH ANALYSIS RESULTS
    Giorgino, F.
    Guerci, B.
    Garcia-Perez, L. E.
    Boye, K.
    Aigner, U.
    Heitmann, E.
    Federici, Orsini M.
    Zimner-Rapuch, S.
    Rosilio, M.
    Norrbacka, K.
    Sapin, H.
    VALUE IN HEALTH, 2020, 23 : S506 - S506
  • [27] Endoscopic Duodenal Mucosal Resurfacing Improves Glycemic and Hepatic Parameters in Patients With Type 2 Diabetes: Data From a First-in-Human Study
    Neto, Manoel Galvao
    Rajagopalan, Harith
    Becerra, Pablo
    Rodriguez, Patricia
    Vignolo, Paulina
    Caplan, Jay
    Rodriguez, Leonardo
    GASTROENTEROLOGY, 2016, 150 (04) : S174 - S174
  • [28] Clinical outcomes after insulin initiation in patients with type 2 diabetes: 6-month data from the INSTIGATE observational study in five European countries
    Liebl, Andreas
    Jones, Stephen
    Benroubi, Marian
    Castell, Conxa
    Goday, Albert
    Charles, Marie Aline
    Smith, Helen T.
    Nicolay, Claudia
    Simpson, Alexander
    CURRENT MEDICAL RESEARCH AND OPINION, 2011, 27 (05) : 887 - 895
  • [29] Insulin/weight ratio may serve as a predictor of success during insulin pump therapy in type 2 diabetes patients: a proof-of-concept study
    Levit, S.
    Philippov, Y. I.
    Cohen, O.
    Weichman, M.
    Azuri, J.
    Manisteski, Y.
    Levit, V.
    DIABETES MELLITUS, 2015, 18 (01): : 70 - 77
  • [30] Human plasma-derived alpha1-proteinase inhibitor in patients with new-onset type 1 diabetes mellitus: A randomized, placebo-controlled proof-of-concept study
    Lagarde, William H.
    Courtney, Kecia L.
    Reiner, Barry
    Steinmann, Kimberly
    Tsalikian, Eva
    Willi, Steven M.
    PEDIATRIC DIABETES, 2021, 22 (02) : 192 - 201
12345